No. of Pages: 227 | Report Code: TIPRE00024253 | Category: Life Sciences
聚合酶链式反应 (PCR) 用于准确的护理诊断，有助于快速识别和确定呼吸道感染的原因。此外，PCR 在住院和门诊环境中受到广泛青睐，有助于促进近年来市场的增长。
预计到 2028 年，亚太地区呼吸道感染诊断 PCR 市场规模将达到 15.1594 亿美元（来自美国） 2021年为7.3747亿美元；预计 2021 年至 2028 年复合年增长率为 10.8%。市场的增长归因于一些关键驱动因素，例如 PCR 技术的不断发展以及 PCR 检测在各种呼吸道感染诊断中的使用增加。然而，替代检测的可用性是阻碍市场增长的主要因素。
由于不断的研究和应用，PCR 已成为各种临床和诊断应用或检查不可或缺的工具。 PCR技术的发展。因此，它为各种传染病的快速护理点诊断提供了许多机会。例如，F. Hoffmann-La Roche Ltd 不断致力于 dPCR 技术的进步。数字PCR（dPCR）已将其应用扩展到临床领域，并已成为重要的临床工具。 dPCR 提供超灵敏和绝对的核酸定量，无需参考标准。因此，它为标准化和比较实验室之间的结果提供了更广泛的方面。此外，目标传染病和遗传性疾病的发病率不断上升；增加投资、资金和赠款；生物标志物分析在疾病诊断中的应用日益广泛等因素可能使 PCR 成为未来不可或缺的工具。此外，PCR检测在疗养院、慢性病护理机构和医院等机构中得到广泛应用，用于识别导致呼吸道疾病爆发的流感病毒感染。因此，多家公司正在提供 PCR 试剂盒，可以检测引起呼吸道疾病的病原体的存在。除了急性和慢性呼吸道疾病发病率不断增加之外，环境和气候条件、空气污染以及新细菌、病毒和病原体的发现等其他因素也可能成为呼吸道感染诊断 PCR 检测的重要增长机会。即将到来的未来。
COVID-19 大流行已广泛影响亚太地区的经济。 COVID-19 病例的增加导致该地区医疗保健系统的压力增加，这也增加了医疗保健系统中诊断测试的需求，支持了该地区该行业的扩张。因此，印度、中国和韩国等国家增强了进行PCR检测的能力。多家制造商正在开发先进的 PCR 检测试剂盒和系统来检测 COVID-19 病毒。此外，高通量分子检测预计将在未来的 COVID-19 大流行管理中发挥核心作用。因此，市场的这种发展可能会促进预测期内市场的增长。
根据类型，亚太地区呼吸道感染诊断 PCR 市场分为实时 PCR (qPCR)、传统 PCR、逆转录酶 (RT-PCR)、数字 PCR、多重 PCR 等。实时 PCR (qPCR) 细分市场在 2021 年占据最大市场份额，预计在预测期内将实现最高的复合年增长率。
基于根据产品类型，亚太地区呼吸道感染诊断 PCR 市场分为试剂和试剂盒、仪器等。试剂和试剂盒细分市场在 2021 年占据最大市场份额，预计在预测期内复合年增长率最高。
根据感染类型，亚太地区呼吸道感染诊断市场的 PCR 分为细菌感染、病毒感染、真菌和其他病原体。 2021 年，病毒感染细分市场占据最大市场份额，预计在预测期内复合年增长率最高。
根据最终用户，亚洲Pacific PCR 呼吸道感染诊断市场分为医院、医生诊所、临床实验室、学术和研究机构、生物技术和制药公司等。 2020 年，临床实验室细分市场占据最大市场份额，预计在预测期内复合年增长率最高。
< /p>
一些主要和次要来源与这份关于亚太地区呼吸道感染诊断 PCR 市场报告相关的机构包括全球疾病负担 (GBD)、澳大利亚肺脏基金会 (ALF) 和国家医学图书馆。
< p>
Strategic insights for Asia Pacific PCR for Respiratory Infection Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 737.47 Million |
| Market Size by 2028 | US$ 1,515.94 Million |
| Global CAGR (2021 - 2028) | 10.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific PCR for Respiratory Infection Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific PCR for Respiratory Infection Diagnostics Market is valued at US$ 737.47 Million in 2021, it is projected to reach US$ 1,515.94 Million by 2028.
As per our report Asia Pacific PCR for Respiratory Infection Diagnostics Market, the market size is valued at US$ 737.47 Million in 2021, projecting it to reach US$ 1,515.94 Million by 2028. This translates to a CAGR of approximately 10.8% during the forecast period.
The Asia Pacific PCR for Respiratory Infection Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific PCR for Respiratory Infection Diagnostics Market report:
The Asia Pacific PCR for Respiratory Infection Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific PCR for Respiratory Infection Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific PCR for Respiratory Infection Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific PCR for Respiratory Infection Diagnostics Market
